Table 5.
Results of multiple regression analysis with symptom domains as dependent variables and cytokines/chemokines/growth factors, adverse childhood experiences (ACEs) and negative life events (NLEs) as explanatory variables.
| Dependent variables | Explanatory variables | Coefficients of input variables | Model statistics | |||||
|---|---|---|---|---|---|---|---|---|
| β | t | p | R2 | F | df | p | ||
| #1. Pure depression | Model | 0.52 | 24.63 | Apr-91 | < 0.001 | |||
| IL-16 | 0.523 | 5.67 | < 0.001 | |||||
| CCL3 | − 0.313 | − 3.88 | < 0.001 | |||||
| ACE + NLEs | 0.219 | 2.43 | 0.017 | |||||
| SCGF | 0.171 | 2.19 | 0.031 | |||||
| #2 Pure anxiety | Model | 0.503 | 23.03 | Apr-91 | < 0.001 | |||
| IL-16 | 0.509 | 5.43 | < 0.001 | |||||
| ACE + NLEs | 0.281 | 3.1 | 0.003 | |||||
| CCL3 | − 0.222 | − 2.81 | 0.006 | |||||
| Education | − 0.149 | − 1.99 | 0.049 | |||||
| #2. Physiosomatic symptoms | Model | 0.62 | 24.24 | Jun-89 | < 0.001 | |||
| IL-16 | 0.709 | 6.68 | < 0.001 | |||||
| ACE + NLEs | 0.225 | 2.68 | 0.009 | |||||
| CCL3 | − 0.321 | − 3.87 | < 0.001 | |||||
| Sex | 0.255 | 3.55 | 0.001 | |||||
| sIL-1RA | − 0.231 | − 2.53 | 0.013 | |||||
| IL-8 | 0.19 | 2.32 | 0.023 | |||||
| #4. Pure FF | Model | 0.498 | 22.58 | Apr-91 | < 0.001 | |||
| IL-16 | 0.715 | 5.5 | < 0.0010.00.002 | |||||
| CIRS | − 0.365 | − 3.18 | 0.008 | |||||
| ACE + NLEs | 0.248 | 2.7 | 0.035 | |||||
| Sex | 0.164 | 2.14 | ||||||
| #5. Melancholia | Model | 0.568 | 40.36 | Mar-92 | < 0.001 | |||
| IL-16 | 0.32 | 3.27 | 0.002 | |||||
| ACEQ24710 | 0.31 | 3.89 | < 0.001 | |||||
| SCGF | 0.247 | 2.8 | 0.006 | |||||
| #6. GIS | Model | 0.494 | 17.55 | May-90 | < 0.001 | |||
| CCL3 | − 0.431 | − 4.6 | < 0.001 | |||||
| CCL11 | 0.316 | 3.83 | < 0.001 | |||||
| ACE + NLEs | 0.202 | 2.41 | 0.018 | |||||
| M-CSF | 0.35 | 3.97 | < 0.001 | |||||
| IL-8 | 0.238 | 2.82 | 0.006 | |||||
| CXCL1 | 0.218 | 2.46 | 0.016 | |||||
| #7. Insomnia | Model | 0.57 | 30.21 | Apr-91 | < 0.001 | |||
| IL-16 | 0.568 | 4.52 | < 0.001 | |||||
| ACE + NLEs | 0.208 | 2.49 | 0.015 | |||||
| sIL-1RA | − 0.246 | − 2.59 | 0.011 | |||||
| SCGF | 0.234 | 2.41 | 0.018 | |||||
IL interleukin, SCGF stem cell growth factor, sIL-1RA soluble IL-1 receptor antagonist, sex males = 1, females = 0, CIRS compensatory immunoregulatory system, TRAIL tumor necrosis factor-related apoptosis-inducing ligand.